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Abstract: Background: Aggressive treatment to achieve complete obliteration of brain arteriovenous
malformation (AVM) is necessary in patients with a recent history of hemorrhage. The major drawback
of Gamma knife radiosurgery (GKRS) alone for AVM is risk of bleeding during the latent period
until the AVM occludes. At our center, patients who present with ruptured AVMs are frequently
offered GKRS followed by embolization. The goal of this study was to compare outcomes of
embolization for patients who have previously undergone GKRS for ruptured AVMs. Methods:
A database including 150 GKRS for ruptured AVMs between November 2008 and October 2017 was
reviewed. The embolized group was selected by including AVMs with post-GKRS embolization.
The non-embolized group was defined as AVMs treated by GKRS alone. Outcomes including
obliteration rate, incidence of repeat hemorrhage, and delayed cyst formation were compared
between two groups. The predictive factors related to AVM obliteration and complications were
analyzed. Results: The study consisted of 81 patients in the non-embolized group and 17 patients
in the embolized group. Statistically significant differences were detected between the two groups
with respect to age, Pollock-Flickinger score, Spetzler-Martin (SM) grade, eloquence of adjacent brain,
and presence of aneurysms. The embolized group included more AVMs with larger median nidus
volume. The predictive factors for the obliteration of ruptured AVMs were nidus volume, SM grade,
Virginia Radiosurgery AVM Scale (VRAS), and Pollock-Flickinger score and for the subsequent
hemorrhage were marginal dose, nidus volume, SM grade, VRAS, and Pollock-Flickinger score.
The obliteration rates and complication rates after GKRS between groups were not significantly
different. However, this study demonstrated statistically significant difference in the cumulative
incidence of obliteration in AVMs with SM grade III and IV (p = 0.037). Conclusion: Although the
current study demonstrated similar results in patients who underwent GKRS with and without
embolization, the embolized group included more AVMs with larger nidus volume, higher SM grade,
Pollock-Flickinger score, and aneurysm, which have a lower chance of obliteration and a higher
probability of repeat hemorrhage. GKRS followed by embolization appears to be a beneficial approach
for the treatment of ruptured AVMs that are at risk for obliteration failure and repeat hemorrhage
during the latency period after single-session GKRS alone. Further studies involving a larger number
of cases and continuous follow-up are necessary to confirm our conclusions.
Keywords: arteriovenous malformation (AVM); cerebrovascular disease (CVD); embolization;
gamma knife radiosurgery (GKRS); intracerebral hemorrhage; radiosurgery; Spetzler-Martin grade
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1. Introduction
Intracranial hemorrhage is the most devastating complication of intracranial arteriovenous
malformations (AVM). Without treatment, the overall risk of a spontaneous hemorrhage from a brain
AVM has been reported to range from 2% to 5% per year [1–3]. The risk may increase with intranidal
aneurysms, deep venous drainage, a single draining vein, venous stenosis, high mean arterial pressure
in the feeder, diffuse morphology, periventricular location, and larger nidus size [4–6]. However,
morbidity and mortality rates associated with hemorrhage are very high [7]. Furthermore, initial AVM
rupture has been shown to increase the risk of subsequent rupture [4]. Previous hemorrhage has
been reported as one of the significant factors for further bleeding [1,8] and aggressive treatment
to achieve complete obliteration is necessary in patients with a recent history of hemorrhage [9].
The treatment options include endovascular embolization, gamma knife radiosurgery (GKRS), surgical
resection, and multimodality approaches using these three techniques. GKRS has been established as
an effective treatment option for intracranial AVMs, especially with small or medium nidi located in
eloquent or deep regions [10–12]. The major drawback of radiosurgical AVM treatment is the risk of
bleeding during the latent period until the AVM is occluded [13]. This limitation is most critical for
ruptured AVMs, which have a high subsequent rupture risk within the first year after hemorrhage.
GKRS and embolization are increasingly being used in combination for larger, complicated AVMs
and especially for ruptured AVMs. The benefits of embolization before GKRS include reduced AVM
volume, allowing application of higher radiation dose to the margin of the smaller target volume
with a better obliteration rate and fewer complications [10]; eradicating angiographic predictors of
hemorrhage [14]; and reducing symptoms associated with arterial steal or venous hypertension [15].
However, several studies have demonstrated that pre-GKRS embolization may be disadvantageous
in treating AVMs. Pre-GKRS embolization may obscure brain AVM nidus delineation, both by
superimposition of embolic material [1] and the presence of collateral feeding vessels [16]. A shielding
effect caused by embolization materials with high atomic mass has also been suggested to obscure
brain AVM nidus delineation [17]. Lastly, embolization may induce hypoxia, making the AVM tissue
less radiosensitive and increasing its angiogenic activity [18].
At our facility, patients who present with an intracranial hemorrhage requiring hematoma
evacuation and decompression are candidates for surgical resection. Patients who have been ruled out
as surgical candidates are offered GKRS followed by embolization, instead of GKRS after embolization
due to the several disadvantages described above. After a short interval, following endovascular
embolization can be used to treat the remaining AVM. During the post-GKRS period, the risk of AVM
repeat rupture has been reduced by endovascular embolization. In this study, we report the results of
a retrospective analysis of outcomes for all patients who presented to our institution with ruptured




A database including 150 cases of patients with ruptured AVMs who underwent GKRS between
November 2008 and October 2017 at our hospital was retrospectively reviewed. The embolized
group comprised of AVMs with post-GKRS embolization. The non-embolized group was defined as
AVMs treated by GKRS alone. All patients presented with hemorrhage confirmed by non-contrast
enhanced computed tomography (CT) imaging. This study excluded patients who had follow-up for
less than 2 years or who had been previously treated by resection or embolization in our hospital or
at another institution. All patients had at least one post-GKRS magnetic resonance imaging (MRI)
or cerebral angiography follow-up study at our hospital available for analysis. Patient clinical data,
including demographic characteristics, imaging findings before embolization and GKRS, radiosurgical
parameters, and follow-up images, were reviewed. Spetzler-Martin (SM) grade, Virginia Radiosurgery
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AVM Scale (VRAS), and Pollock-Flickinger score were used to classify AVMs. This study obtained full
ethical approval from the institutional review board.
2.2. Gamma Knife Radiosurgery
The procedure for GKRS has been previously described [19,20]. In brief, all patients underwent
stereotactic frame placement and stereotactic planning neuroimaging, using MRI and digital subtraction
angiography (DSA). Radiosurgery was performed using the Leksell Gamma Knife Perfexion Unit
(Elekta AB, Elekta Company, Stockholm, Sweden). The AVM nidus was delineated using stereotactic
MRI, including T1-weighted contrast-enhanced and T2-weighted imaging sequences, and DSA.
Dose planning was performed by a neurosurgeon and a medical physicist depending on AVM nidus
location and calculated lesion volume.
2.3. Endovascular Embolization
Planning of endovascular treatment was based on consensus by a multidisciplinary stroke team
meeting after the careful evaluation of 3-dimentional angiograms. Endovascular embolization was
performed for the purpose of reducing nidus flow and decreasing the risk of subsequent hemorrhage
during the latent period. The embolized group underwent transarterial embolization using N-butyl
cyanoacrylate (NBCA) or non-adhesive copolymer ethylene vinyl alcohol (Onyx; Medtronic, Irvine,
California, CA, USA) at our institution. Post-GKRS embolization was scheduled for the earliest possible
date after GKRS, considering the patients’ medical and neurologic conditions.
2.4. Neuroimaging Follow-up and Outcomes Assessment
After GKRS, all patients underwent clinical evaluation and MRI/MR angiography (MRA) including
time-of-flight (TOF) studies at 6-month intervals for the first 2 years and then annually thereafter.
Once the nidus was considered obliterated on MRI/MRA, a cerebral angiogram was recommended.
Total obliteration of the AVM was defined as complete absence of nidus filling on angiogram [20]. If the
patient missed an angiogram, the AVM was considered obliterated if there was no flow void on MRI or
vascular filling on MRA [20]. If obliteration of the AVM nidus was not observed within 3–4 years after
initial GKRS, salvage treatments for residual nidi were recommended. The AVM nidus was measured
at treatment and after treatment using the latest available follow-up MRI scan [9]. For this group of
patients who underwent repeat GKRS, images from the initial treatment and images before the repeat
GKRS were used for analysis. Measurements were made on T1-weighted contrast-enhanced imaging.
The nidus was defined as the contrast-enhancing portion of the AVM, excluding any draining veins
or arterial feeders [9]. Delayed cyst formation was defined as a fluid-filled cavity with an enhancing
nodular lesion on T1-weighted contrast-enhanced imaging following GKRS for AVM. Incidence of
repeat hemorrhage and delayed cyst formation were assessed using MRI throughout follow-ups.
In case of presentation of any neurologic symptoms, an emergent non-contrast enhanced CT imaging
was performed to reveal any complications.
2.5. Statistical Analysis
The Chi-square test, Fisher exact test, and Mann-Whitney U-test were used to examine differences
between the embolized and non-embolized groups. Descriptive statistics are presented as the median
and range for continuous variables and as frequency and percentage for categorical variables. Since all
continuous variables did not satisfy normality, they were analyzed by the Mann-Whitney U-test.
Descriptive statistics were presented as medians (Q1: cumulative percentage of 25%, Q3: cumulative
percentage of 75%). The rates of obliteration, repeat hemorrhage, and delayed cyst formation after
treatment were assessed in both groups. Obliteration and complication rates were compared between
the two groups using Chi-square test or Fisher’s exact test, as appropriate. The Kaplan-Meier method
was used to investigate different groups in association with the obliteration and complication rates after
stratification with the log-rank test. Univariate analyses were performed using the Cox proportional
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hazards regression model to analyze the predictive factors of AVM obliteration and complications.
The hazard ratio (HR) and 95% confidence interval (CI) were calculated. Statistical significance was
indicated by a p value less than 0.05. All analyses were performed using statistical software (SAS,
version 9.4, SAS Inc., Cary, NC, USA and R package, version 3.6.0).
3. Results
3.1. Patient Demographics, AVM Characteristics, and Radiosurgical Parameters
Among 150 GKRS for ruptured AVMs, 14 cases of repetitive GKRS were identified, therefore a total
of 136 patients underwent GKRS for ruptured AVMs. Fourteen patients were excluded because
their follow-up periods were less than 2 years and they did not undergo follow-up imaging studies.
Twenty-four patients who underwent embolization or surgical resection before GKRS were also
excluded. In total, 98 patients were enrolled in this study. The non-embolized group consisted of
81 patients and the embolized group consisted of 17 patients.
The median interval between embolization and GKRS was 6.3 days (range 0–21 days). The embolic
agents were Onyx, used in 12/17 procedures (70.6%), and NBCA, used in 5/17 procedures (29.4%). Table 1
presents patient demographics, AVM characteristics, and radiosurgical parameters in detail. Statistically
significant differences were detected between the two groups with respect to age, Pollock-Flickinger
score, SM grade distribution, eloquence of adjacent brain, and presence of aneurysms. None of the
patients in the non-embolized group had AVMs with flow-related aneurysm. The embolized group
included more AVMs with larger median nidus volume, although it was not significantly different
between the two groups.
Table 1. Comparison of baseline demographic data, arteriovenous malformation (AVM) characteristics,
and radiosurgical parameters.
Non-Embolized (n = 81) Embolized (n = 17) p-Value
Median age 22 (14, 38) 39 (29, 48) 0.0045
Sex 0.3073
Male 49 (60.5%) 8 (47.1%)
Female 32 (39.5%) 9 (52.9%)
Median FU time, month 47 (36, 67) 47 (41, 59) 0.9738
Median marginal dose, Gy 16 (15, 18) 16 (16, 17) 0.6685
Median isodense line 50% (50.0%) 50% (50.0%)
Median nidus volume, cm3 2.14 (0.87, 5.41) 3.30 (2.10, 5.70) 0.4084
Median remnant nidus volume, cm3 0 (0, 0.40) 0.29 (0, 0.90) 0.1792
Median delta nidus volume, % 100 (89.2, 100) 89.2 (81.8, 100) 0.1221
VRAS 0.1161
0 0 (0%) 0 (0%)
1 34 (42.0%) 3 (17.6%)
2 13 (16.0%) 3 (17.6%)
3 20 (24.7%) 8 (47.2%)
4 14 (17.3%) 3 (17.6%)
Pollock-Flickinger score 0.95 (0.59, 1.37) 1.30 (1.05, 1.95) 0.0316
<1 44 (54.3%) 4 (23.5%)
1.01–1.50 20 (24.7%) 5 (29.4%)
1.51–2.00 6 (7.4%) 5 (29.4%)
>2 11 (13.6%) 3 (17.7%)
SM grade 0.0023
I 42 (51.8%) 2 (11.8%)
II 28 (34.6%) 11 (64.7%)
III 11 (13.6%) 3 (17.6%)
IV 0 (0%) 1 (5.9%)
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Table 1. Cont.
Non-Embolized (n = 81) Embolized (n = 17) p-Value
Eloquence 0.029
Noneloquent 67 (82.7%) 10 (58.8%)
Eloquent 14 (17.3%) 7 (41.2%)
Venous drainage
Superficial only 62 (76.5%) 10 (58.8%) 0.132
Deep 19 (23.5%) 7 (41.2%)
Presence of Aneurysm 12 (14.8%) 8 (47.0%) 0.0060
Intranidal 12 (14.8%) 6 (35.3%)
Flow-related 0 (0%) 2 (11.7%)
FU = follow up, SM = Spetzler-Martin, VRAS = Virginia Radiosurgery AVM scale. Delta nidus volume =
(nidus volume – remnant nidus volume/nidus volume) x100, Descriptive statistics are presented as medians
(Q1: cumulative percentage of 25%, Q3: cumulative percentage of 75%); Boldface type indicates statistical
significance (p < 0.05).
3.2. Imaging Outcome—AVM Obliteration
In the embolized group, MRI/MRA or angiographic obliteration after GKRS was achieved in eight
patients (47.1%). In the non-embolized group, MRI/MRA or angiographic obliteration after GKRS
was achieved in 51 patients (63.0%). The difference was not significant according to the Chi-square
test (p = 0.2232). The Kaplan-Meier curves for obliteration are shown in Figure 1A. The cumulative
incidence of obliteration was not significantly different between the two groups (p = 0.4281, Log rank
test). The Cox regression model for factors regarding time to obliteration is shown in Table 2.
In univariate analyses for the two groups, those with a higher nidus volume VRAS, Pollock-Flickinger
score, and SM grade before GKRS showed a significant inverse correlation for obliteration at the
last follow-up.
3.3. Complications – Repeat Hemorrhage/Delayed Cyst Formation
Post-GKRS complications included repeat hemorrhage and cyst formation. In the embolized group,
none of the 17 patients experienced repeat hemorrhage at the last follow-up. In the non-embolized
group, eight repeat hemorrhage episodes were noted after GKRS. The difference was not significant
according to the Chi-square test (p = 0.3439). The Kaplan-Meier curves for repeat hemorrhage are
shown in Figure 1B. The cumulative incidence of hemorrhage was not significantly different between
the two groups (p = 0.2099, Log rank test). The Cox regression model for factors regarding time to
repeat hemorrhage is shown in Table 2. In the univariate analysis, those with a higher nidus volume
before GKRS, remnant nidus volume after GKRS, higher VRAS, Pollock-Flickinger score, and SM grade
showed a significantly higher likelihood of repeat hemorrhage at the last follow-up. Those with higher
marginal dose and delta nidus volume (%) (nidus volume before GKRS–remnant nidus volume after
GKRS) showed a significant inverse correlation for repeat hemorrhage at the last follow-up.
In the embolized group, there was one patient with radiation-induced delayed cyst formation.
In the non-embolized group, six patients showed delayed cyst formations after GKRS. The difference
did not achieve statistical significance in the Chi-square test (p = 0.9999). The Kaplan-Meier curves for
delayed cyst formation are shown in Figure 1C. The cumulative incidence of cyst formation was not
significantly different between the two groups (p = 0.8341, Log rank test). The Cox regression model for
factors regarding time to cyst is shown in Table 2. In the univariate analysis, those with a higher nidus
volume before GKRS showed significance for delayed cyst formation at the last follow-up. Those with
higher delta nidus volume showed a significant inverse correlation for delayed cyst formation at the
last follow-up.
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Figure 1. (A) Kaplan-Meier curves for total obliteration confirmed by magnetic resonance (MR)
imaging/MR angiography or cerebral angiogram after gamma knife radiosurgery (GKRS) for ruptured
arteriovenous malformations (AVMs) with and without endovascular embolization. No statistical
difference was noted between the 2 groups (Log-rank test, p = 0.43). (B) Kaplan-Meier curves for
repeat hemorrhage after GKRS for ruptured AVM with and without endovascular embolization.
No statistical difference was noted between the 2 groups (Log-rank test, p = 0.21). (C) Kaplan-Meier
curves for delayed cyst formation after GKRS for ruptured AVM with and without endovascular
embolization. No statistical difference was noted between the 2 groups (Log-rank test, p = 0.83).
(D) Kaplan-Meier curves for total obliteration confirmed by MRI/MRA or cerebral angiogram after
GKRS for ruptured AVM belonging to SM grade III and IV with and without endovascular embolization.
Statistical significance was noted between the 2 groups (Log-rank test, p = 0.0372).
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Table 2. Predictive factors for time to obliteration, repeat hemorrhage, and delayed cyst formation of arteriovenous malformations (AVMs) in 98 patients: Cox regression.
Obliteration Hemorrhage Cyst Formation
Univariate Analysis Univariate Analysis Univariate Analysis
Factors HR CI p-Value HR CI p-Value HR CI p-Value
Post GKRS Embo 0.746 (0.354, 1.574) 0.4418 0.302 (0.015, 6.220) 0.4377 0.798 (0.096, 6.633) 0.8346
Age 0.992 (0.977, 1.008) 0.3486 1.010 (0.971, 1.049) 0.6305 0.990 (0.942, 1.040) 0.6785
Female sex 1.268 (0.757, 2.122) 0.3671 0.462 (0.093, 2.291) 0.3448 1.097 (0.245, 4.921) 0.9033
Marginal dose, Gy 1.010 (0.983, 1.039) 0.4621 0.438 (0.259, 0.741) 0.0021 0.605 (0.340, 1.075) 0.0865
Nidus volume, cm3 0.981 (0.971, 0.991) 0.0003 1.010 (1.006, 1.015) <0.0001 1.009 (1.002, 1.015) 0.0119
Remnant nidus volume, cm3 0.940 (0.737, 1.199) 0.6187 1.013 (1.006, 1.021) 0.0003 1.013 (0.998, 1.027) 0.0855
Delta nidus volume, % 20.168 (0.132, 3085.252) 0.2418 0.956 (0.933, 0.979) 0.0002 0.959 (0.924, 0.996) 0.0304
Higher SM grade 0.480 (0.319, 0.721) 0.0004 3.082 (1.359, 6.986) 0.0070 1.216 (0.438, 3.380) 0.7073
Higher VRAS 0.579 (0.449, 0.747) <0.0001 3.759 (1.448, 9.757) 0.0065 1.192 (0.597, 2.378) 0.6185
Higher Pollock–Flickinger score 0.390 (0.246, 0.619) <0.0001 2.819 (1.674, 4.746) <0.0001 2.066 (0.992, 4.304) 0.0525
Aneurysm 1.031 (0.546, 1.947) 0.9255 1.276 (0.257, 6.321) 0.7655 0.670 (0.080, 5.595) 0.7113
HR: Hazard ratio, CI: confidence interval, VRAS = Virginia Radiosurgery AVM scale GKRS = Gamma knife radiosurgery, Embo = embolization, SM = Spetzler-Martin; Delta nidus volume
= (nidus volume – remnant nidus volume / nidus volume) × 100; Descriptive statistics are presented as medians (Q1: cumulative percentage of 25%, Q3: cumulative percentage of 75%);
Boldface type indicates statistical significance ( p < 0.05).
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3.4. Subgroup Analysis—SM Grade III&IV
Subgroup analysis was further performed on AVMs with SM grade III and IV. The non-embolized
group consisted of 11 patients and the embolized group consisted of four patients. No statistically
significant differences were detected between the two groups with respect to patient demographics,
AVM characteristics, or radiosurgical parameters. No statistically significant difference was detected
between the two groups with respect to obliteration, repeat hemorrhage, or delayed cyst formation
(p = 0.5165, p = 0.5165, and p = 0.999, respectively). The cumulative incidence of repeat hemorrhage and
delayed cyst formation were not significantly different between the two groups (p = 0.2374, p = 0.5637,
respectively, Log rank test). However, statistical significance was observed in the cumulative incidence
of obliteration (p = 0.0372, Log rank test) (Figure 1D).
4. Case Illustration
4.1. Case 1
A 28-year old patient was admitted to the emergency department with sudden onset of headache
and nausea. The non-contrast enhanced CT scan revealed an acute intraventricular hemorrhage in
the left lateral ventricle (Figure 2A). A subsequent CT angiography (CTA) suggested the presence of
an AVM, which was confirmed by DSA, revealing a SM grade III AVM in the left temporal lobe with
feeders from the left anterior choroidal artery and left posterior cerebral artery with venous ectasia,
draining to the left basal vein of Rosenthal (Figure 2B). Also, multiple focal bulging lesions were
found at the distal anterior choroidal artery, suggesting intranidal aneurysms. Twenty days after her
first admission, the patient underwent GKRS (3.30cm3, 18 Gy to 50% of the isodense line; Figure 2C).
Two days after GKRS, she underwent Onxy embolization (Figure 2D). The final angiogram showed
near complete occlusion of the AVM nidus with multiple intranidal aneurysms. At her imaging
follow-up examination (24 months after GKRS), the MRI/MRA revealed no flow void (Figure 2E).
Figure 2. (A) The non-contrast enhanced computed tomography showed an acute intraventricular
hemorrhage. (B) The digital subtraction angiography confirmed a Spetzler-Martin grade III AVM in
the left temporal lobe with feeders from the left anterior choroidal artery and left posterior cerebral
artery with venous ectasia, draining to the left basal vein of Rosenthal. (C) Gamma knife radiosurgery
(3.30 cm3, 18 Gy to 50% of the isodense line). (D) The final angiogram after Onxy embolization showed
near complete occlusion of the AVM nidus with multiple intranidal aneurysms. (E) The last follow up
magnetic resonance imaging (24 months after GKRS) revealed neither residual nidus nor flow void.
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4.2. Case 2
A 20-year old patient had presented with sudden onset of left homonymous hemianopsia.
The non-contrast enhanced CT scan revealed an acute intracerebral hemorrhage in the right
parieto-occipital lobe (Figure 3A). The DSA revealed a SM grade II AVM with feeders from the
right parieto-occipital and calcarine arteries and draining to the vein of Galen (Figure 3B). Twelve days
later, the patient underwent GKRS (2.20 cm3, 16 Gy to 50% of the isodense line; Figure 3C). Five days
after GKRS, she underwent NBCA 25% embolization (Figure 3D). The final angiogram showed near
total occlusion of the AVM nidus. The visual field defect had been recovered without any neurologic
deficit. At her imaging follow-up examination (28 months after GKRS), the DSA revealed complete
obliteration of the AVM (Figure 3E).
Figure 3. (A) The non-contrast enhanced computed tomography revealed an acute intracerebral
hemorrhage in the right parieto-occipital lobe. (B) The digital subtraction angiography revealed a SM
grade II AVM with feeders from the right parieto-occipital and calcarine arteries and draining to the
vein of Galen. (C) Gamma knife radiosurgery (2.20 cm3, 16 Gy to 50% of the isodense line). (D) The final
angiogram after NBCA 25% embolization showed near total occlusion of the AVM nidus. (E) The digital
subtraction angiography (DSA) revealed complete obliteration of the AVM.
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5. Discussion
We started this study to compare the outcomes of ruptured AVMs at a higher risk of subsequent
hemorrhage treated with and without post-GKRS embolization and to investigate the potential benefits
of post-GKRS embolization. We hypothesized that the potential benefits of post-GKRS embolization
would lower the risk of subsequent hemorrhage and increase the rate of obliteration of previously
ruptured AVMs.
Univariate analysis showed that patients with a larger nidus volume, higher SM grade,
higher VRAS, and higher Pollock-Flickinger score AVMs have a significantly lower chance of
obliterating a nidus (p = 0.003, 0.004, <0.001, and <0.001, respectively) (Table 2). AVM volume
reportedly has an inverse relationship with obliteration after GKRS [10,21–25]. The median nidus
volume was larger in the embolized group compared to the non-embolized group, although this
was not statistically significant (Table 1). The previous study reported that a lower SM grade,
lower BRAS, and lower Pollock-Flickinger score were statistically significant for predicting the
probability of AVM obliteration [23]. In the present study, there were statistically significant differences
between the embolized and non-embolized group with respect to the SM grade distribution and
Pollock-Flickinger score. Thus, post-GKRS embolization could offer a high obliteration of AVM with
larger nidus volume and higher grading scores, which might have a lower chance of obliteration
without post-GKRS embolization.
Using univariate analysis, the marginal dose, nidus volume, SM grade, VRAS,
and Pollock-Flickinger score were identified as predictive factors for subsequent hemorrhage in
the present study (Table 2). Our findings are consistent with Huo et al. [23]. The authors suggested
that deep location, aneurysm, increased volume, decreased maximum dose, decreased marginal
dose, higher VRAS score, and higher Pollock-Flickinger score were associated with postradiosurgical
hemorrhage. In our study, there was no significant difference between the two groups regarding VRAS.
However, the embolized group included more AVMs with higher SM grade and Pollock-Flickinger
score, which are those with a higher probability of repeat hemorrhage. Although the univariate analysis
in our study did not identify the presence of aneurysm as a predictor of latent period hemorrhage after
GKRS, the embolized group included more AVMs with intranidal or flow-related aneurysm. The risk
of intracranial hemorrhage in patients with AVMs and associated aneurysms is higher than that in
patients with AVMs alone [26,27]. Furthermore, patients with aneurysms associated with ruptured
AVMs are at higher risk for subsequent hemorrhage. Thus, we recommend aggressive management
to treat aneurysms associated with AVMs by endovascular embolization. This treatment rationale
is based on reports of aneurysms disappearing after the successful obliteration of AVMs [26,28].
In addition, embolization can reduce the flow in shunting vessels by blocking high-flow fistulas [29].
The use of embolization with permanent agents can play an important role in high-grade AVMs with
intranidal or perinidal aneurysms or fistulae [30]. Furthermore, the selective embolization of high-flow
arterial feeders can alleviate flow-related neurological symptoms or deficits. Although the post-GKRS
hemorrhage rate was not significantly different between the two groups, none of the 17 patients in the
embolized group experienced a latent period repeat hemorrhage after GKRS. Previous studies have
suggested a dose-volume-tolerance relationship for the occurrence of complications [15,31]. We also
found that radiation dose and nidus volume were critical predictors for the occurrence of repeat
hemorrhage. Nidus size may be reduced with endovascular embolization to reduce the complication
rate and achieve complete obliteration of ruptured AVMs.
Several studies have analyzed the effect of prior embolization on AVM radiosurgery outcomes;
they proposed that embolization prior to GKRS may reduce the final obliteration rate. Kano et al.
demonstrated that prior embolization reduced the total obliteration rate after GKRS [10]. Pollock et
al. investigated factors related to successful outcomes after radiosurgery in 220 patients with AVM,
including 40 who underwent initial embolization. Embolization prior to GKRS was identified as
a negative predictor for complete nidus obliteration [32]. Several potential mechanisms have been
suggested for the diminished rate of GKRS-induced obliteration with prior embolization, as mentioned
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in the Introduction section. The unfavorable effects of pre-GKRS embolization on obliteration are also
attributed to nidus angioarchitectural complexity. Larger AVMs with more complex angioarchitecture
are usually selected for combined management, consistent with the distribution of AVMs identified
in the two groups of our study, regarding nidus volume, SM grade, and Pollock-Flickinger score.
Nidus angioarchitecture may be a significant factor in the statistical evaluation of the effect of prior
embolization on AVM obliteration after GKRS because of the inverse correlation between nidus
angioarchitectural complexity and post-GKRS obliteration rate [21]. Thus, a higher angioarchitectural
complexity may partially explain the lower obliteration rates observed in embolized AVMs [21].
High-grade AVMS, those of SM grade III or higher, are extremely difficult to treat by single-session
GKRS alone [33]. Despite the small sample size (11 patients in the non-embolized group and four
patients in the embolized group), the subgroup analysis of SM grades III and IV showed a significant
difference in the cumulative incidence of obliteration (p = 0.0372, Log rank test) (Figure 1D).
In the present study, it was unusual to demonstrate six (7.4%) delayed cyst formation in the
non-embolized group after GKRS with the short latency period. In the systematic review by Ilyas et al.,
the overall rate of post-SRS cyst formation was 3.0%, which is half the percentage in our report,
and the mean latency period to post-SRS cyst formation was 78 months (6.5 years) [34]. However,
several studies have showed cyst formation after GKRS with a short latency period [10,35–40].
Hasegawa et al. presented that prior hemorrhage before GKRS was a significant factor for late
AREs including cyst formation [41]. Pan et al. also found statistical significance between prior
AVM hemorrhage and cyst formation [42]. The cause of the development of cyst formation remains
unclear. Histopathological examination of resected cysts suggests that cyst formation occurs secondary
to a chronic, organized response to radiation-induced vascular telangiectasia and wall damage,
which promotes microhemorrhage and protein exudation [36]. Among the possible mechanisms
suggested by Maiuri et al., a hypothesis describing a cyst formed by intracerebral hemorrhage itself
is one possible mechanism for cyst formation. It is possible that prior AVM hemorrhage increases
tissue susceptibility to damage, thereby increasing the risk of cyst formation. The present study only
concerns ruptured AVMs. One possible reason for the high incidence (7.4%) of cyst formation with
a relatively short latency period is that we only included patients who had previously undergone
hemorrhage before GKRS.
Study Limitations
The major limitation of the present study includes the retrospective review at a single institution
with a small number of patients (17 patients with embolization). Regarding the subgroup analysis
performed on AVMs with SM grade III and IV, this consisted of 11 patients in the non-embolized
group and 4 patients in the embolized group. Although statistical significance was observed in
cumulative incidence of obliteration between the two groups, it may not be considered to prove
the clinical significance because of the small sample size. The selection bias may play a critical role
in patient selection and the decision to choose treatment because larger AVMs with more complex
angioarchitecture are usually selected for combined management. In addition, the treatment bias
associated with endovascular embolization being decided by “accessibility” was unavoidable. Lastly,
our institution started to treat larger AVMs with staged-GKRS rather than single-session GKRS. In this
study, only first single-session GKRS data of patients were used for analysis.
6. Conclusions
In the present study, predictive factors for the obliteration of ruptured AVMs were nidus volume,
SM grade, VRAS, and Pollock-Flickinger score. In addition, our study showed that marginal dose,
nidus volume, SM grade, VRAS, and Pollock-Flickinger score significantly affected subsequent
hemorrhage after GKRS. Although the current study demonstrated similar results in patients who
underwent GKRS with and without embolization, the embolized group included more AVMs with larger
nidus volume, higher SM grade, Pollock-Flickinger score, and aneurysm, which have a lower chance of
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obliteration and a higher probability of repeat hemorrhage. GKRS followed by embolization appears
to be a beneficial approach for the treatment of ruptured AVMs that are at risk for obliteration failure
and repeat hemorrhage during the latency period after single-session GKRS alone. Further studies
involving a larger number of cases and continuous follow-up are necessary to confirm our conclusions.
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